Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave

Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave

Bibliographic Details
Main Authors:	Read, JM, Green, CA, Harrison, EM, Docherty, AB, Funk, S, Harrison, J, Girvan, M, Hardwick, HE, Turtle, L, Dunning, J, Nguyen-Van-Tam, JS, Openshaw, PJM, Baillie, JK, Semple, MG
Format:	Journal article
Language:	English
Published:	Elsevier 2021

Similar Items

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study
by: Russell, CD, et al.
Published: (2021)

The burden and dynamics of hospital-acquired SARS-CoV-2 in England
by: Cooper, BS, et al.
Published: (2023)

Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK
by: Bloom, CI, et al.
Published: (2021)

Seasonal and pandemic influenza: 100 years of progress, still much to learn
by: Dunning, WJ, et al.
Published: (2020)

Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study
by: Sullivan, MK, et al.
Published: (2021)

Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK
by: Docherty, AB, et al.
Published: (2021)

Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study
by: Swann, OV, et al.
Published: (2020)

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
by: Liew, F, et al.
Published: (2022)

Coronavirus (SARS-COV-2) in early stages of the pandemic; overview
by: Al-Gheethi, Adel, et al.
Published: (2020)

Neuropsychiatric disorders following SARS-CoV-2 infection
by: Harrison, PJ, et al.
Published: (2023)

SARS-CoV-2 environmental contamination from hospitalised patients with COVID-19 receiving aerosol-generating procedures
by: Winslow, RL, et al.
Published: (2021)

Distinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study
by: Millar, JE, et al.
Published: (2022)

Transmission of community- and hospital-acquired SARS-CoV-2 in hospital settings in the UK: a cohort study
by: Mo, Y, et al.
Published: (2021)

Outcomes of COVID-19 related hospitalisation among people with HIV in the ISARIC WHO Clinical Characterisation Protocol UK Protocol: prospective observational study
by: Geretti, AM, et al.
Published: (2020)

Delayed mucosal antiviral responses despite robust peripheral inflammation in fatal COVID-19
by: Sidhu, JK, et al.
Published: (2023)

The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection
by: Goldswain, H, et al.
Published: (2023)

Restricting the spread of SARS-CoV-2 or safeguarding mental health: a false dichotomy?
by: Taquet, M, et al.
Published: (2022)

Exposed seronegative: cellular immune responses to SARS-CoV-2 in the absence of seroconversion
by: Jay, C, et al.
Published: (2023)

Airway models in a pandemic: suitability of models in modeling SARS-CoV-2
by: Teo, Andrew, et al.
Published: (2022)

Phylogenetic and phylodynamic approaches to understanding and combating the early SARS-CoV-2 pandemic
by: Attwood, SW, et al.
Published: (2022)

HLA-E-restricted SARS-CoV-2-specific T cells from convalescent COVID-19 patients suppress virus replication despite HLA class Ia down-regulation
by: Yang, H, et al.
Published: (2023)

Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score
by: Knight, SR, et al.
Published: (2020)

Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol
by: Knight, SR, et al.
Published: (2021)

Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults
by: Killingley, B, et al.
Published: (2022)

Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study.
by: Drake, TM, et al.
Published: (2021)

Genomic reconstruction of the SARS-CoV-2 epidemic in England
by: Vöhringer, HS, et al.
Published: (2021)

The silent pandemic: Emergent antibiotic resistances following the global response to SARS-CoV-2
by: Mahoney, Andrew R., et al.
Published: (2021)

SARS-CoV-2 human challenge studies - establishing the model during an evolving pandemic
by: Rapeport, G, et al.
Published: (2021)

Primary care preparedness for the SARS-CoV-2 pandemic: a survey of NHS GPs
by: Pilbeam, C, et al.
Published: (2021)

International comparison of guidelines for managing neonates at the early phase of the SARS-CoV-2 pandemic
by: Lavizzari, A, et al.
Published: (2020)

Interventions targeting non-symptomatic cases can be important to prevent local outbreaks: SARS-CoV-2 as a case study
by: Lovell-Read, F, et al.
Published: (2021)

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
by: Docherty, AB, et al.
Published: (2020)

Recovery from Covid-19 critical illness: a secondary analysis of the ISARIC4C CCP-UK cohort study and the RECOVER trial
by: Pauley, E, et al.
Published: (2021)

Models to inform neutralizing antibody therapy strategies during pandemics: the case of SARS-CoV-2
by: Guttieres, Donovan, et al.
Published: (2021)

Absence of SARS-CoV-2 antibodies in pre-pandemic plasma from children and adults in Vietnam
by: Chau, NVV, et al.
Published: (2021)

The evolution of SARS-CoV-2
by: Markov, PV, et al.
Published: (2023)

A comparison of persistence of SARS-CoV-2 variants on stainless steel
by: Pottage, T, et al.
Published: (2021)

The utility of wastewater surveillance for monitoring SARS-CoV-2 prevalence
by: Mills, C, et al.
Published: (2024)

Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera
by: Roper, KJ, et al.
Published: (2023)

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2
by: Kim, KS, et al.
Published: (2021)